
Keywords: اسید داکوزاگزوائونیک; ANOVA; analysis of variance; BMI; body mass index; CVD; cardiovascular disease; DHA; docosahexaenoic acid; EFSA; European Food Safety Authority; EPA; eicosapentaenoic acid; HDL-C; high-density lipoprotein cholesterol; LDL-C; low-density lipoprotein choles